• M. Kolesnyk SI «Institute of Nephrology NAMS of Ukraine»
  • N. Stashevska SI«Institute of Nephrology NAMS of Ukraine»
  • N. Stepanova SI«Institute of Nephrology NAMS of Ukraine»
  • V. Dryyanskaya SI«Institute of Nephrology NAMS of Ukraine»
  • A. Rudenko SI «Institute of Nephrology NAMS of Ukraine»
  • V. Kruglykov SI «Institute of Nephrology NAMS of Ukraine»
  • O. Kornylina SI «Institute of Nephrology NAMS of Ukraine»
Keywords: recurrent pyelonephritis, mucosal immunity, hyperoxaluria, lysozyme, lactoferrin, secretory immunoglobulin A.


Summary: The aim of our study was to compare the performance of mucosal immunity in urine and saliva of patients with chronic recurrent pyelonephritis subject to availability of hyperoxaluria.

Material and methods. To observational cross–sectional study included 40 women with chronic recurrent pyelonephritis, aged 21 to 48 years (31.6±7.7). Depending on the availability hyperoxaluria (oxalate excretion in the urine than 0.45 mmol per day) patients were divided into II Groups: for I (n=29) included women with hyperoxaluria, to II (n=11) – includes patients with normal excretion oxalate (7.2±2.4 vs 43.8±5.2; p <0.001). State of mucosal immunity was assessed by determining the content of lysozyme, lactoferrin, secretory immunoglobulin A (sIg A) and tumor necrosis factor alpha (TNF– a) in urine samples and content sIg A and class antibodies sIg A to lipopolysaccharide (LPS) of gram–negative bacteria (anti–LPS–sIgA) in saliva.

Results. We have identified significantly higher levels of sIg A and anti–LPS–sIgA in the saliva ofpatients with recurrent pyelonephritis with hyperoxaluria (298±104 vs 150.1±79.3 mg/1, p<0.001) and (0.353±0.16 vs 0.211±0.09, p<0.001), respectively. In the urine ofwomen of group I we havefound a statistically significant increase in the content of TNF– a 44 [16.2–130.5] vs 21 [14.2–3.45] pg/ml (p=0.04) and lysozyme 14.0[2.5– 36.5]vs 1.45[0.12–7.5]ng/ml (p=0.002). All the studied parameters (anti–LPS–sIg A in saliva and sIg A, lactofer– rin and lysozyme urine) had a direct correlation with the level of daily oxalate excretion.


Conclusions. Overproduction of indicators of mucosal immunity may be explained by the formation of intestinal dysbiosis under the influence of continuous antibiotic therapy. The imbalance of intestinal microflora, in turn, leads to the formation of hyperoxaluria and increases the production of antibodies to LPS, sIg A, lactoferrin and lysozyme.



Download data is not yet available.


Алекушина А.В. Комплексный способ диагностики выраженности дисбактериоза кишечника / A. В. Алекушина // Клин. лаб. диагн. – 2010. – № 11. – С. 48–51.

Колесник М. О. Патогенез пієлонефриту : що ми знаємо і що ні / М. О. Колесник, Н. М. Степанова, B. Є. Дріянська, А. В. Руденко, Н. А. Калініна, В. Т. Кругліков // Український журнал нефрології та діалізу. – 2011. – № 3 (31). – С. 34–46.

Нормальна мікрофлора урогенітального тракту та її роль у підтриманні імунітету слизових оболонок / О. С. Воронкова, О. А. Сірокваша, Т. М. Полішко, А. І. Вінніков // Вісник Дніпропетровського університету. – Біологія. Екологія. – 2008. – Вип. 16, т. 1. – С. 51–56.

Рабсон Л. Основы медицинской иммунологии: пер. с англ. / Л. Рабсон, А. Ройт, П. Делвиз. – М.: Мир, 2006. – 320 с.

Реброва О. Ю. Статистический анализ медицинских данных. Применение пакета прикладных программ STATISTICA / О. Ю. Реброва. – М. : Медиасфера, 2003. – 312 с.

Bordon Yvonne. Mucosal immunology: A wee immune response / Bordon Yvonne [Електронний ресурс] // Nature Reviews Immunology. – 2013. – Vol. 13. – Режим доступу : http://www.nature.com/nri/jour– nal/v13/n4/full/nri3426.html

Guidelines on Urological Infections // M. Grabe (Chairman), M. C. Bishop, T. E. Bjerklund–Johansen [et al.] // European Association of Urology. – 2013.

Hatch M. Intestinal transport of an obdurate anion: oxalate / Hatch M., Freel R/ W. // Urol. Res. – 2005. – Vol. 33. – P. 1–16.

Hatch M. The Roles and Mechanisms of Intestinal Oxalate Transport in Oxalate Homeostasis / M. Hatch, R. W. Freel // Seminars in Nephrology. – 2008 – Vol 28. – № 2. – Р. 143–151.

Kolesnyk M. Effect of hyperoxaluria on the progression of chronic kidney disease in women with recurrent uncomplicated pyelonephritis / M. Kolesnyk, N.Stepanova, L.Surzhko, N.Stashevska // Nephrology Dialysis Transplantation. – 2012. – Vol. 27 (Supplement 2). – P. 107.

Lieske J. C. Use of a probiotic to decrease enteric hyperoxaluria / Lieske J. C., Goldfarb D. S., De Simone C., [et al.] // Kidney Int. – 2005/ – Vol. 68. – P. 1244–1249.

Principles of mucosal immunology / Phillip D. Smith et al. – Garland Science, 2013. – 529 p.

Raheela Mohsin. Recurrent urinary tract infections in females / Raheela Mohsin, Khurram Mutahir Siddiqui // J Pak Med Assoc. – 2010. – Vol. 60. – No. 1. – P. 55–59.

Sensitivity of Human Strains of Oxalobacter for– migenes to Commonly Prescribed Antibiotics / J. N. Lange, Kyle D. Wood, H. Wong, R. Otto, [et al.] // Urology. – 2012. – Vol. 79(6). – P.1286–1289.

Stef Robijn. Hyperoxaluria: a gut–kidney axis? / Stef Robijn, Bernd Hoppe, Benjamin A Vervaet, Patrick C D’Haesel et al // Kidney International. – 2011. – № 80. – P. – 1146–1158.

Williams А. Immunology : mucosal and body surface defences / Andrew Williams, Tracy Hussell, Clare Lloydby. – Chichester, West Sussex; Hoboken, NJ : Wiley–Blackwell, 2012. – 398 p.

Abstract views: 218
PDF Downloads: 111
How to Cite
Kolesnyk, M., Stashevska, N., Stepanova, N., Dryyanskaya, V., Rudenko, A., Kruglykov, V., & Kornylina, O. (2014). HYPEROXALURIA AND BIOMARKERS OF MUCOSAL IMMUNITY IN PATIENTS WITH RECURRENT PYELONEPHRITIS. Ukrainian Journal of Nephrology and Dialysis, (3(43), 42-48. https://doi.org/10.31450/ukrjnd.3(43).2014.07

Most read articles by the same author(s)